FP7H2020HORIZON
TP21 GmbH
- Country
- DEGermany
- Defence projects
- 0
- Projects, all programmes
- 20
- As coordinator
- 0
- EU contribution (CORDIS)
- EUR 5,425,087
- Active
- 2008 to 2023
Projects
20 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| IntReALL 2020International Study for Treatment of Childhood Relapsed ALL 2020 | HORIZON | 2023 | Participant | EUR 318,750 |
| Microb-AI-omeFederated artificial intelligence for privacy-preserving international stratification of colorectal cancer patients | HORIZON | 2023 | Participant | EUR 400,000 |
| AISNIntegrating AI in Stroke Neurorehabilitation | HORIZON | 2022 | Participant | EUR 310,000 |
| REPO4EUPrecision drug REPurpOsing For EUrope and the world | HORIZON | 2022 | Participant | EUR 396,250 |
| ENDOSCAPEENDOSCAPE, a clinically applicable non-viral gene delivery technology | H2020 | 2019 | Participant | EUR 370,000 |
| VirtualBrainCloudPersonalized Recommendations for Neurodegenerative Disease | H2020 | 2018 | Participant | EUR 376,250 |
| PAMMOTHPhotoacoustic/Ultrasound Mammoscopy for evaluating screening-detected abnormalities in the breast | H2020 | 2017 | Participant | EUR 222,500 |
| NISCIAntibodies against Nogo-A to enhance plasticity, regeneration and functional recovery after acute spinal cord injury, a multicenter European clinical proof of concept trial | H2020 | 2016 | Participant | EUR 278,125 |
| CVENTRisk assessment of plaque rupture and future cardiovascular events (CVENT) by multi-spectral photoacoustic imaging | H2020 | 2016 | Participant | EUR 223,750 |
| BtRAINBrain barriers training | H2020 | 2015 | Partner | EUR 0 |
| OPERAMOPtimising thERapy to prevent Avoidable hospital admissions in the Multimorbid elderly | H2020 | 2015 | Participant | EUR 269,000 |
| IACOBUSDiagnosis and Monitoring of Inflammatory and Arthritic diseases using a COmbined approach Based on Ultrasound, optoacoustic and hyperSpectral imaging | FP7 | 2013 | Participant | EUR 235,680 |
| UniVaxA “Universal” Influenza Vaccine through Synthetic, Dendritic Cell-Targeted, Self-Replicating RNA Vaccines | FP7 | 2013 | Participant | EUR 268,000 |
| RESPONSIFYGenome-based biomarkers leading to validated molecular diagnostic tests for response prediction in breast cancer | FP7 | 2012 | Participant | EUR 288,000 |
| FULLPHASEFully integrated real time multi-wavelength photoacoustics for early disease detection | FP7 | 2012 | Participant | EUR 283,401 |
| INTREALLInternational study for treatment of childhood relapsed ALL 2010 with standard therapy, systematic integration of new agents, and establishment of standardized diagnostic and research | FP7 | 2011 | Participant | EUR 345,600 |
| JUSTBRAINBlood-brain barrier junctions as targets for paracellular drug delivery to the brain | FP7 | 2009 | Participant | EUR 175,800 |
| METACANCERIdentification and validation of new breast cancer biomarkers based on integrated metabolomics | FP7 | 2008 | Participant | EUR 244,360 |
| NHECDNano Health-Environment Commented Database | FP7 | 2008 | Participant | EUR 182,221 |
| SKINSPECTIONMULTIMODAL SKIN INSPECTION WITH HYBRID ACOUSTIC & OPTICAL SPECTROSCOPIC IMAGING | FP7 | 2008 | Participant | EUR 237,400 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.